Stay updated with breaking news from Alpha Da. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
- Interim data read-out of the first five treated patients demonstrated successful delivery in all five cases, as well as no product-related Serious Adverse Events - - First five patients received...
- Interim data read-out of the first five treated patients demonstrated successful delivery in all five cases, as well as no product-related Serious Adverse Events -
Alpha Tau Medical (NASDAQ:DRTS – Free Report) had its target price reduced by Piper Sandler from $12.00 to $8.00 in a research report released on Friday morning, Benzinga reports. Piper Sandler currently has an overweight rating on the stock. A number of other research analysts have also recently weighed in on the stock. HC Wainwright […]
Atalaya Capital Management LP grew its position in Alpha Tau Medical Ltd. (NASDAQ:DRTSW – Free Report) by 256.3% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 280,474 shares of the company’s stock after purchasing an additional 201,755 shares during the period. Atalaya Capital Management LP’s […]
Alpha Tau Medical Ltd. (NASDAQ:DRTSW – Get Free Report) was the target of a significant growth in short interest in the month of October. As of October 31st, there was short interest totalling 10,000 shares, a growth of 56.3% from the October 15th total of 6,400 shares. Based on an average trading volume of 9,800 […]